Drug treatment programs' HCV service delivery to their HCV positive clients

Addiction Research and Theory

Volumn 14, Issue 3, 2006, Pages 289-302

  Astone Twerell, Janetta M ^a   Strauss, Shiela M ^a   Hagan, Holly ^a   Des Jarlais, Don C ^b  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Drug treatment programs; HCV service delivery; Hepatitis C; Injection drug users; Methadone maintenance programs; Telephone survey

Indexed keywords

EID: 33746858910     PISSN: 16066359     EISSN: 14767392     Source Type: Journal    
DOI: 10.1080/16066350500262742     Document Type: Article

References (35)

1. Alter, M. J., & Moyer, L. A. (1998). The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl 1), S6-S10.
2. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341, 556-562.
3. Astone, J., Strauss, S. M., Vassilev, Z. P., & Des Jarlais, D. C. (2003). Provision of hepatitis C education in a nationwide sample of drug treatment programs. Journal of Drug Education, 33, 107-117.
4. Backmund, M., Meyer, K., Von Zielonka, M., & Eichenlaub, D. (2001). Treatment of hepatitis C infection in injection drug users. Hepatology, 34, 188-193.
5. Centers for Disease Control and Prevention (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR, 47, 1-39.
6. Centers for Disease Control and Prevention (2003). Hepatitis C Fact Sheet. Retrieved January 22, 2005 from www.cdc.gov/hepatitis.
7. Clapp, J. D. (1998). Organizational factors related to AIDS/HIV education in outpatient substance abuse treatment units. Journal of Health and Social Policy, 9, 1-13.
8. D'Aunno, T., Vaughn, T. E., & McElroy, P. (1999). An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. Journal of Health and Social Behavior, 40, 175-192.
9. Edlin, B. R. (2002). Prevention and treatment of hepatitis C in injection drug users. Hepatology, 36(5 Suppl 1), S210-S219.
10. Edlin, B. R., Seal, K. H., Lorvick, J., Kral, A. H., Ciccarone, D. H., Moore, L. D., et al. (2001). Is it justifiable to withhold treatment for hepatitis C from illicit drug users? New England Journal of Medicine, 345, 211-215.
11. Friedmann, P. D., Alexander, J. A., & D'Aunno, T. A. (1999). Organizational correlates of access to primary care and mental health services in drug abuse treatment units. Journal of Substance Abuse Treatment, 16, 71-80.
12. Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl 1), S11-S19.
13. Hagan, H., McGough, J. P., Thiede, H., Weiss, S., Hopkins, S., & Alexander, E. R. (1999). Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology, 149, 203-213.
14. Hagan, H., Thiede, H., Weiss, H. S., Hopkins, S. G., Duchin, J. S., & Alexander, E. R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91, 42-46.
15. Koch, M., & Banys, P. (2001). Liver transplantation and opioid dependence. The Journal of the American Medical Association, 285, 1056-1058.
16. McCarthy, J. J., & Flynn, N. (2001). Hepatitis C in methadone maintenance patients: Prevalence and public policy implications. Journal of Addictive Diseases, 20, 19-31.
17. McCoy, H. V., Messiah, S. E., & Zhao, W. (2002). Improving access to primary health care for chronic drug abusers: An innovative systematic intervention for providers. Journal of Behavioral Health Services Research, 29, 445-457.
18. McMahon, J., & Tortu, S. (2003). A potential hidden source of hepatitis C infection among non-injecting drug users. Journal of Psychoactive Drugs, 35, 455-460.
19. Metzger, D. S., Navaline, H., & Woody, G. E. (1998). Drug abuse treatment as AIDS prevention. Public Health Reports, 113(Suppl 1), 97-106.
20. Pearlman, B. L. (2004). Hepatitis C infection: A clinical review. Southern Medical Journal, 97, 364-373.
21. Pratt, C.-C. N. U., Paone, D., Carter, B. J., & Layton, M. C. (2002). Hepatitis C screening and management practices: A survey of drug treatment and syringe exchange programs in New York City. American Journal of Public Health, 92, 1254-1256.
22. Rosenberg, S. D., Goodman, L. A., & Osher, F. C. (2001). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health, 91, 42-46.
23. Rosenblum, A., Nuttbrock, L., McQuistion, H. L., Magura, S., & Joseph, H. (2001). Hepatitis C and substance use in a sample of homeless people in New York City. Journal of Addictive Diseases, 20, 15-25.
24. Sorensen, J. L., Masson, C. L., & Perlman, D. C. (2002). HIV/hepatitis prevention in drug abuse treatment programs: Guidance from research. Science and Practice Perspectives, 1, 4-11.
25. Stein, M. D., Maksad, J., & Clarke, J. (2001). Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence, 61, 211-215.
26. Stephenson, J. (2001). Former addicts face barriers to treatment for HCV. The Journal of the American Medical Association, 285, 118-126.
27. Strauss, S. M., Astone, J. M., Des Jarlais, D. C., & Hagan H. (2004a). A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States. Drug and Alcohol Dependence, 73, 227-236.
28. Strauss, S. M., Astone, J. M., Hagan, H., & Des Jarlais, D. C. (2004b). The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units. Journal of Urban Health, 81, 38-47.
29. Strauss, S. M., Astone, J., Vassilev, Z. P., Des Jarlais, D. C., & Hagan, H. (2003). Gaps in the drug-free and methadone treatment program response to hepatitis C. Journal of Substance Abuse Treatment, 24, 291-297.
30. Strauss, S. M., Falkin, G. P., Vassilev, Z., Des Jarlais, D. C., & Astone, J. (2002). A nationwide survey of hepatitis C services provided by drug treatment programs. Journal of Substance Abuse Treatment, 22, 55-62.
31. Sylvestre, D. L. (2002). Treating hepatitis C in methadone maintenance patients: An interim analysis. Drug and Alcohol Dependence, 67, 117-123.
32. Tortu, S., Neaigus, A., McMahon, J., & Hagen, D. (2001). Hepatitis C among non-injecting drug users: A report. Substance Use and Misuse, 36, 523-534.
33. Van Ameijden, E. J., van den Hoek, J. A., Mientjes, G. H., & Coutinho, R. A. (1993). A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. European Journal of Epidemiology, 9, 255-262.
34. Winstock, A. R., Sheridan, J., Lovell, S., Farrell, M., & Strang, J. (2000). National survey of hepatitis testing and vaccination services provided by drug services in England and Wales. European Journal of Clinical Microbiology and Infectious Diseases, 19, 823-828.
35. Zweben, J. E. (2001). Hepatitis C: Education and counseling issues. Journal of Addictive Diseases, 20, 33-42.